Jun 8, 2026 07:01AM
Jun 2, 2026 08:00AM
Apr 30, 2026 07:03AM
Jan 22, 2026 04:09PM
Jan 5, 2026 07:02AM
Dec 15, 2025 07:03AM
Nov 4, 2025 12:02PM RedHill Biopharma secures final $10.5 million court judgment
Nov 4, 2025 09:30AM
Oct 22, 2025 04:51PM
Oct 20, 2025 09:05AM
Oct 6, 2025 08:01AM
Sep 29, 2025 07:02AM
Aug 20, 2025 09:03AM
Aug 18, 2025 09:03AM RedHill receives $1.1 million in licensing payments for Talicia
Jul 21, 2025 09:01AM
Jul 1, 2025 12:01PM
Apr 28, 2025 07:05AM
Apr 17, 2025 04:08PM
Apr 16, 2025 07:02AM
Mar 18, 2025 07:00AM
Feb 25, 2025 07:04AM RedHill Biopharma (RDHL) Licenses RHB-102 for Commercialization Worldwide Excluding North America to Hyloris for up to $60 Million in Potential Milestone Payments Plus Royalties
Feb 4, 2025 07:02AM
Dec 10, 2024 07:06AM
Dec 2, 2024 07:00AM
Oct 22, 2024 07:01AM
Oct 14, 2024 07:01AM
Oct 1, 2024 07:08AM
Sep 30, 2024 07:05AM RedHill (RDHL) Announces New U.S. Coronavirus Patent for Opaganib, Valid Through 2041
Sep 5, 2024 07:01AM
Sep 3, 2024 07:06AM
Aug 26, 2024 07:00AM
Aug 19, 2024 07:00AM
Aug 16, 2024 07:01AM
Jul 22, 2024 07:02AM
Jul 9, 2024 08:04AM RedHill Biopharma (RDHL) Terminates License Agreement for Aemcolo

404,872 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All